Correlation Between Harbor Health and IShares Biotechnology
Can any of the company-specific risk be diversified away by investing in both Harbor Health and IShares Biotechnology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Harbor Health and IShares Biotechnology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Harbor Health Care and iShares Biotechnology ETF, you can compare the effects of market volatilities on Harbor Health and IShares Biotechnology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Harbor Health with a short position of IShares Biotechnology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Harbor Health and IShares Biotechnology.
Diversification Opportunities for Harbor Health and IShares Biotechnology
0.77 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Harbor and IShares is 0.77. Overlapping area represents the amount of risk that can be diversified away by holding Harbor Health Care and iShares Biotechnology ETF in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares Biotechnology ETF and Harbor Health is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Harbor Health Care are associated (or correlated) with IShares Biotechnology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares Biotechnology ETF has no effect on the direction of Harbor Health i.e., Harbor Health and IShares Biotechnology go up and down completely randomly.
Pair Corralation between Harbor Health and IShares Biotechnology
Given the investment horizon of 90 days Harbor Health Care is expected to generate 0.89 times more return on investment than IShares Biotechnology. However, Harbor Health Care is 1.13 times less risky than IShares Biotechnology. It trades about -0.05 of its potential returns per unit of risk. iShares Biotechnology ETF is currently generating about -0.07 per unit of risk. If you would invest 2,711 in Harbor Health Care on September 13, 2024 and sell it today you would lose (98.00) from holding Harbor Health Care or give up 3.61% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Harbor Health Care vs. iShares Biotechnology ETF
Performance |
Timeline |
Harbor Health Care |
iShares Biotechnology ETF |
Harbor Health and IShares Biotechnology Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Harbor Health and IShares Biotechnology
The main advantage of trading using opposite Harbor Health and IShares Biotechnology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Harbor Health position performs unexpectedly, IShares Biotechnology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares Biotechnology will offset losses from the drop in IShares Biotechnology's long position.Harbor Health vs. Horizon Kinetics Medical | Harbor Health vs. Ginkgo Bioworks Holdings | Harbor Health vs. Myriad Genetics |
IShares Biotechnology vs. First Trust Exchange Traded | IShares Biotechnology vs. Horizon Kinetics Medical | IShares Biotechnology vs. Harbor Health Care | IShares Biotechnology vs. Fidelity MSCI Health |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |